Dept. of Human Nutrition, Univ. of Illinois at Chicago, IL 60612, USA.
Am J Physiol Gastrointest Liver Physiol. 2010 May;298(5):G634-42. doi: 10.1152/ajpgi.00249.2009. Epub 2010 Mar 4.
Adipose tissue dysfunction, featured by insulin resistance and/or dysregulated adipokine production, plays a central role not only in disease initiation but also in the progression to nonalcoholic steatohepatitis and cirrhosis. Promising beneficial effects of betaine supplementation on nonalcoholic fatty liver disease (NAFLD) have been reported in both clinical investigations and experimental studies; however, data related to betaine therapy in NAFLD are still limited. In this study, we examined the effects of betaine supplementation on hepatic fat accumulation and injury in mice fed a high-fat diet and evaluated mechanisms underlying its hepatoprotective effects. Male C57BL/6 mice weighing 25 +/- 0.5 (SE) g were divided into four groups (8 mice/group) and started on one of four treatments: control diet, control diet supplemented with betaine, high-fat diet, and high-fat diet supplemented with betaine. Betaine was supplemented in the drinking water at a concentration of 1% (wt/vol) (anhydrous). Our results showed that long-term high-fat feeding caused NAFLD in mice, which was manifested by excessive neutral fat accumulation in the liver and elevated plasma alanine aminotransferase levels. Betaine supplementation alleviated hepatic pathological changes, which were concomitant with attenuated insulin resistance as shown by improved homeostasis model assessment of basal insulin resistance values and glucose tolerance test, and corrected abnormal adipokine (adiponectin, resistin, and leptin) productions. Specifically, betaine supplementation enhanced insulin sensitivity in adipose tissue as shown by improved extracellular signal-regulated kinases 1/2 and protein kinase B activations. In adipocytes freshly isolated from mice fed a high-fat diet, pretreatment of betaine enhanced the insulin signaling pathway and improved adipokine productions. Further investigation using whole liver tissues revealed that betaine supplementation alleviated the high-fat diet-induced endoplasmic reticulum stress response in adipose tissue as shown by attenuated glucose-regulated protein 78/C/EBP homologous protein (CHOP) protein abundance and c-Jun NH(2)-terminal kinase activation. Our findings suggest that betaine might serve as a safe and efficacious therapeutic tool for NAFLD by improving adipose tissue function.
脂肪组织功能障碍,其特征为胰岛素抵抗和/或脂联素产生失调,不仅在疾病起始中起核心作用,而且在向非酒精性脂肪性肝炎和肝硬化的进展中也起核心作用。在临床研究和实验研究中均已报道甜菜碱补充对非酒精性脂肪性肝病(NAFLD)有良好的有益作用;然而,关于甜菜碱治疗 NAFLD 的资料仍然有限。在这项研究中,我们研究了甜菜碱补充对高脂饮食喂养的小鼠肝脂肪堆积和损伤的影响,并评估了其肝保护作用的机制。体重为 25 +/- 0.5(SE)g 的雄性 C57BL/6 小鼠分为四组(每组 8 只),并开始接受以下四种处理之一:对照饮食、对照饮食加甜菜碱、高脂饮食和高脂饮食加甜菜碱。甜菜碱以 1%(wt/vol)(无水)的浓度添加到饮水中。我们的结果显示,长期高脂喂养导致了小鼠的非酒精性脂肪性肝病,表现为肝脏中性脂肪过度堆积和血浆丙氨酸氨基转移酶水平升高。甜菜碱补充缓解了肝组织学变化,这与胰岛素抵抗的减弱相一致,表现为基础胰岛素抵抗值的稳态模型评估改善和葡萄糖耐量试验改善,以及异常脂联素(脂联素、抵抗素和瘦素)产生得到纠正。具体而言,甜菜碱补充通过增强细胞外信号调节激酶 1/2 和蛋白激酶 B 的激活增强了脂肪组织的胰岛素敏感性。在从高脂饮食喂养的小鼠分离的脂肪细胞中,甜菜碱预处理增强了胰岛素信号通路并改善了脂联素产生。进一步用全肝组织进行的研究显示,甜菜碱补充缓解了高脂饮食引起的脂肪组织内质网应激反应,表现为葡萄糖调节蛋白 78/C/EBP 同源蛋白(CHOP)蛋白丰度和 c-Jun NH2-末端激酶激活的减弱。我们的研究结果表明,甜菜碱可能通过改善脂肪组织功能,成为治疗非酒精性脂肪性肝病的一种安全有效的治疗工具。